Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3,750 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
International workshop: what is needed to ensure outcome measures for Rett syndrome are fit-for-purpose for clinical trials? June 7, 2023, Nashville, USA.
Downs J, Pichard DC, Kaufmann WE, Horrigan JP, Raspa M, Townend G, Marsh ED, Leonard H, Motil K, Dietz AC, Garg N, Ananth A, Byiers B, Peters S, Beatty C, Symons F, Jacobs A, Youakim J, Suter B, Santosh P, Neul JL, Benke TA. Downs J, et al. Among authors: peters s. Trials. 2024 Dec 21;25(1):845. doi: 10.1186/s13063-024-08678-6. Trials. 2024. PMID: 39709426 Free PMC article.
Phase I clinical trial testing the dose escalation and expansion of Pressurized IntraThoracic Hyperthermic Aerosol Cisplatin administration (PITHAC) for the management of pleural carcinosis.
Chriqui LE, Abdelnour-Berchtold E, Zanfrini E, Devesa-Perez S, Gonzalez M, Krueger T, Ellefsen K, Destaillats A, Bonnet D, Hübner M, Bouchaab H, Bassani-Sternberg M, Peters S, Cavin S, Perentes JY. Chriqui LE, et al. Among authors: peters s. Cancer Treat Res Commun. 2024 Dec 17;42:100858. doi: 10.1016/j.ctarc.2024.100858. Online ahead of print. Cancer Treat Res Commun. 2024. PMID: 39708537
Bad habits that stick: adhesive tape use practices and beliefs.
Fischer J, Kleppel R, Mathew M, Gilmore M, Hegarty-Moore L, Maryanski M, Peters S, Smith K, Roncaioli S, Smith J, Gallagher MC, DelPilar-Morales E, Haessler S. Fischer J, et al. Among authors: peters s. Infect Control Hosp Epidemiol. 2024 Dec 20:1-3. doi: 10.1017/ice.2024.175. Online ahead of print. Infect Control Hosp Epidemiol. 2024. PMID: 39703078
Longer-term survival, quality of life, and cost-effectiveness of conservative versus liberal oxygenation targets in critically ill children: a pre-specified analysis from Oxy-PICU, a multicentre, open, parallel-group, randomised controlled trial.
Moler-Zapata S, Peters MJ, Gould DW, Giallongo E, Orzol M, Ray S, Thomas K, Chang I, O'Neill L, Agbeko R, Au C, Draper E, Elliot-Major L, Lampro L, Pappachan J, Peters S, Ramnarayan P, Rowan KM, Harrison DA, Mouncey PR, Sadique Z; Oxy-PICU Investigators of the Paediatric Critical Care Society Study Group (PCCS-SG). Moler-Zapata S, et al. Among authors: peters s. Lancet Child Adolesc Health. 2025 Jan;9(1):16-24. doi: 10.1016/S2352-4642(24)00294-3. Lancet Child Adolesc Health. 2025. PMID: 39701658 Clinical Trial.
Tocilizumab and immune signatures for targeted management of cytokine release syndrome in immune checkpoint therapy.
Daoudlarian D, Segot A, Latifyan S, Bartolini R, Joo V, Mederos N, Bouchaab H, Demicheli R, Abdelhamid K, Ferahta N, Doms J, Stalder G, Noto A, Mencarelli L, Mosimann V, Berthold D, Stravodimou A, Sartori C, Shabafrouz K, Thompson JA, Wang Y, Peters S, Pantaleo G, Obeid M. Daoudlarian D, et al. Among authors: peters s. Ann Oncol. 2024 Dec 17:S0923-7534(24)04979-2. doi: 10.1016/j.annonc.2024.12.004. Online ahead of print. Ann Oncol. 2024. PMID: 39701282
Lurbinectedin is an effective alternative to platinum rechallenge and may restore platinum sensitivity in patients with sensitive relapsed small cell lung cancer.
Dómine Gómez M, Subbiah V, Peters S, Sala MA, Trigo J, Paz-Ares L, Nieto Archilla A, Gomez Garcia J, Alvarez García C, López-Vilariño de Ramos JA, Kahatt Lopez C, Fernandez CM. Dómine Gómez M, et al. Among authors: peters s. Expert Rev Anticancer Ther. 2024 Dec 12:1-15. doi: 10.1080/14737140.2024.2438067. Online ahead of print. Expert Rev Anticancer Ther. 2024. PMID: 39660812 Review.
Why BMJ Leader is focusing on healthcare leadership in Africa.
Hargovan M, Peters SM, Busari JO. Hargovan M, et al. Among authors: peters sm. BMJ Lead. 2024 Dec 10:leader-2024-001164. doi: 10.1136/leader-2024-001164. Online ahead of print. BMJ Lead. 2024. PMID: 39658063 No abstract available.
Sex differences in the efficacy of angiotensin receptor blockers on kidney and cardiovascular outcomes among individuals with type 2 diabetes and diabetic kidney disease: post hoc analyses of the RENAAL and IDNT trials.
de Vries ST, Pena MJ, Tye SC, Peters SAE, van Raalte DH, Arnott C, Voors AA, Mol PGM, Denig P, Heerspink HJL. de Vries ST, et al. Among authors: peters sae. Diabetologia. 2024 Dec 10. doi: 10.1007/s00125-024-06325-y. Online ahead of print. Diabetologia. 2024. PMID: 39656268
3,750 results